Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvador Alonso

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of Surgical Oncology|November 24, 2020
The Landmark Series: Chemotherapy for Non-Metastatic Colon CancerSalvador Alonso, Leonard Saltz
Disease Models & Mechanisms|September 29, 2021
Engineering chromosome rearrangements in cancerSalvador Alonso, Lukas E Dow
Annual Review of Nutrition|May 26, 2018
Nutritional Regulation of Intestinal Stem CellsSalvador Alonso, Ömer H Yilmaz
Experimental Hematology|July 30, 2017
Retinoic acid, CYP26, and drug resistance in the stem cell nicheSalvador Alonso, Richard J Jones, Gabriel Ghiaur
Oncotarget|April 28, 2015
Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymesSalvador Alonso, Meng Su, Jace W Jones, et al.
Plos One|June 6, 2015
All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the MicroenvironmentMeng Su, Salvador Alonso, Jace W Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2016
Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adultsJavier Gómez-Vera, Salvador Alonso Gutiérrez-Ávila, David Neri Acosta-Gutiérrez, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in CRCSalvador Alonso, Kevan Chu, Marie J Parsons, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2008
[Merkel cell carcinoma: outcome and role of radiotherapy]R Salvador Alonso, I Lahbabi, M Ben Hassel, et al.
Blood Advances|March 23, 2019
Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3/ITD AML from tyrosine kinase inhibitorsYu-Ting Chang, Daniela Hernandez, Salvador Alonso, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of Surgical Oncology|November 24, 2020
The Landmark Series: Chemotherapy for Non-Metastatic Colon CancerSalvador Alonso, Leonard Saltz
Disease Models & Mechanisms|September 29, 2021
Engineering chromosome rearrangements in cancerSalvador Alonso, Lukas E Dow
Annual Review of Nutrition|May 26, 2018
Nutritional Regulation of Intestinal Stem CellsSalvador Alonso, Ömer H Yilmaz
Experimental Hematology|July 30, 2017
Retinoic acid, CYP26, and drug resistance in the stem cell nicheSalvador Alonso, Richard J Jones, Gabriel Ghiaur
Oncotarget|April 28, 2015
Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymesSalvador Alonso, Meng Su, Jace W Jones, et al.
Plos One|June 6, 2015
All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the MicroenvironmentMeng Su, Salvador Alonso, Jace W Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2016
Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adultsJavier Gómez-Vera, Salvador Alonso Gutiérrez-Ávila, David Neri Acosta-Gutiérrez, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in CRCSalvador Alonso, Kevan Chu, Marie J Parsons, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2008
[Merkel cell carcinoma: outcome and role of radiotherapy]R Salvador Alonso, I Lahbabi, M Ben Hassel, et al.
Blood Advances|March 23, 2019
Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3/ITD AML from tyrosine kinase inhibitorsYu-Ting Chang, Daniela Hernandez, Salvador Alonso, et al.
Pageof 2